日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hospital Addiction Consultation Service and Opioid Use Disorder Treatment: The START Randomized Clinical Trial

医院成瘾咨询服务和阿片类药物使用障碍治疗:START随机临床试验

Ober, Allison J; Murray-Krezan, Cristina; Page, Kimberly; Friedmann, Peter D; Anderson, Jess; Osilla, Karen Chan; Ryzewicz, Stephen; Huerta, Sergio; Mazer, Mia W; Hoskinson, Randall A; Garvey, Richard; Peltz, Alexandra; Watkins, Katherine E; Nuckols, Teryl; IsHak, Waguih William; Mariano, Louis T; Danovitch, Itai

Glioma immunotherapy enhancement and CD8-specific sialic acid cleavage by isocitrate dehydrogenase (IDH)-1.

胶质瘤免疫疗法增强和 CD8 特异性唾液酸裂解由异柠檬酸脱氢酶 (IDH)-1 介导

Cordner Ryan, Jhun Michelle, Panwar Akanksha, Wang HongQiang, Gull Nicole, Murali Ramachandran, McAbee Joseph H, Mardiros Armen, Sanchez-Takei Akane, Mazer Mia W, Fan Xuemo, Jouanneau Emmanuel, Yu John S, Black Keith L, Wheeler Christopher J

Pilot randomized controlled trial of a hospital-based substance use treatment and recovery team (START) to improve initiation of medication for alcohol or opioid use disorder and linkage to follow-up care

一项试点随机对照试验,旨在研究以医院为基础的物质使用治疗和康复团队(START)如何改善酒精或阿片类药物使用障碍患者的药物治疗启动率以及后续护理衔接。

Ober, Allison J; Osilla, Karen C; Klein, David J; Burgette, Lane F; Leamon, Isabel; Mazer, Mia W; Messineo, Gabrielle; Collier, Stacy; Korouri, Samuel; Watkins, Katherine E; Ishak, Waguih; Nuckols, Teryl; Danovitch, Itai

The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-discharge care for hospitalized patients with opioid use disorder

物质使用治疗和康复团队 (START) 研究:一项多中心随机对照试验方案,旨在评估一项干预措施,以改善阿片类药物使用障碍住院患者的药物治疗启动和出院后护理衔接。

Ober, Allison J; Murray-Krezan, Cristina; Page, Kimberly; Friedmann, Peter D; Chan Osilla, Karen; Ryzewicz, Stephen; Huerta, Sergio; Mazer, Mia W; Leamon, Isabel; Messineo, Gabrielle; Watkins, Katherine E; Nuckols, Teryl; Danovitch, Itai